Sight Sciences Inc.

SGHT | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.62

+$0.13 (+1.53%)

Sep 22, 2026, 9:56 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.53%

(1D)

Rating

Updated: Aug 14, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $469.01M

1D Range

8.54 8.64

52W Range

3.19 9.24

Valuation (TTM)

PE -15.16

PB 8.73

EV/EBITDA -16.47

Valuation (NTM)

Forward PE N/A

Forward PEG 2.45

Price Target $7

Cash Flow

FCF Yield -6.6%

SBC Adj. FCF Yield -9.5%

SBC Impact -44.8%

Margins

Gross Margin 88.0%

Operating Margin -33.4%

FCF Margin -36.5%

Growth (CAGR)

Revenue 3Y | 5Y 0.8% | 16.5%

Dil EPS 3Y | 5Y 29.5% | 25.0%

FCF 3Y | 5Y 10.3% | 26.9%

Returns

ROA -28.4%

ROE -50.6%

ROIC -29.3%

Financial Health

Net Cash

$38.98M

Current Ratio 4.95

Interest Coverage -10.65

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its p...

Sector Healthcare

Industry Medical - Devices

Employees 186

IPO Date Jul 14, 2021

Website www.sightsciences.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Downside

-18.79%

Buy (4)

Hold (1)

Sell (0)

Analyst Details ➞